STAT-Related Profiles Are Associated with Patient Response to Targeted Treatments in Locally Advanced SCCHN

The anti-epidermal growth factor receptor antibody cetuximab (Erbitux, CTX) is currently used for the treatment of locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN), as yet with modest effectiveness, prompting for the identification of response predictors to this treatment and...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kotoula, Vassiliki, Lambaki, Sofia, Televantou, Despina, Kalogera-Fountzila, Anna, Nikolaou, Angelos, Markou, Konstantinos, Misailidou, Despina, Syrigos, Konstantinos N, Fountzilas, George
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Neoplasia Press Inc. 2011
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3026408/
https://ncbi.nlm.nih.gov/pubmed/21286377
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak